TYRA
Tyra BiosciencesDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
9
U.S. public peers
Grade Position
Below peers
vs peer average
TYRA vs peer average
29/100
TYRA vs. peer average (D vs. C)
Grade spread
A 2 · B 2 · C 1 · F 2
Graded peers loaded
Coverage
8 graded
89% of tracked
Peer overview
MAZE is the first available peer comparator.
Clinical-stage biotech with similar market capitalization; useful for milestone and financing sensitivity, but not a direct FGFR3 or indication peer.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
TYRA
Tyra Biosciences
MAZE
Maze Therapeutics
Grade
D
F
Momentum
7
8
Value
41
41
Sentiment
65
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Grade position vs MAZE
TYRA / MAZE
Grade Position
Below peers
TYRA vs. peer average (D vs. C)
29/100
Momentum
7
MAZEValue
41
TYRASentiment
65
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs TYRA
MAZE is the first peer returned for this comparison set.